Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase EARLY_PHASE1 2Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1Neoplasms 1Nausea 1Marijuana Abuse 1Dysgeusia 1Cachexia 1Appetitive Behavior 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Cannabidiol × Clear all
NCT04585841 2023-07-24

The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy

University of Copenhagen

Phase 1 Completed
32 enrolled

Appetitive Behavior, Cachexia, Marijuana Abuse, Dysgeusia, Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡